Transaction in Own Shares

* Reuters is not responsible for the content in this press release.

Mon Jun 29, 2009 9:28am EDT

  BAGSVAERD, DENMARK, Jun 29 (MARKET WIRE) -- 
Novo Nordisk A/S - Share repurchase programme


 On 29 January 2009, Novo
Nordisk initiated its share repurchase programme in accordance with the
provisions of the European Commission's regulation no 2273/2003 of 22
December 2003, also referred to as the Safe Harbour rules.

    Under the programme Novo Nordisk will repurchase B shares for an amount
up to DKK 3.0 billion in the period from 29 January 2009 to 5 August 2009.

    Since the announcement as of 22 June 2009, the following transactions
have been made under the programme:


                  Number of Average purchase  Transaction
                   shares        price        value, DKK
Accumulated, last
announcement      7,949,682                  2,199,283,687
22 June 2009         80,000         284.1900    22,735,200
23 June 2009         80,000         284.3000    22,744,000
24 June 2009         75,000         285.7700    21,432,750
25 June 2009         80,000         282.2400    22,579,200
26 June 2009        120,000         268.3710    32,204,520
Accumulated under
the programme     8,384,682                  2,320,979,357

    
With the transactions stated above, Novo Nordisk owns a total of
19,176,741 treasury shares, corresponding to 3.1% of the share capital.
The total amount of shares in the company is 620,000,000 including
treasury shares.

    Novo Nordisk is a healthcare company and a world leader in diabetes care.
In addition, Novo Nordisk has a leading position within areas such as
haemostasis management, growth hormone therapy and hormone replacement
therapy. Novo Nordisk manufactures and markets pharmaceutical products
and services that make a significant difference to patients, the medical
profession and society. With headquarters in Denmark, Novo Nordisk
employs more than 27,900 employees in 81 countries, and markets its
products in 179 countries. Novo Nordisk's B shares are listed on the
stock exchanges in Copenhagen and London. Its ADRs are listed on the New
York Stock Exchange under the symbol 'NVO'. For more information, visit
novonordisk.com.

    Company Announcement no. 37 / 2009


 This announcement was originally
distributed by Hugin. The issuer is  solely responsible for the content
of this announcement.


 
 Copyright Copyright Hugin AS 2009. All rights
reserved.

    



Copyright 2009, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.